Related references
Note: Only part of the references are listed.Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Kenneth E. Schmader et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
Isabel Leroux-Roels et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
Najoua Dendouga et al.
VACCINE (2012)
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2011)
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Philippe Moris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
CD4 T Cell Immunity Is Critical for the Control of Simian Varicella Virus Infection in a Nonhuman Primate Model of VZV Infection
Kristen Haberthur et al.
PLOS PATHOGENS (2011)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster
Anne A. Gershon et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response
Janet E. McElhaney
EXPERT REVIEW OF VACCINES (2009)
Varicella-Zoster Virus-Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
Adriana Weinberg et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors
G. N. Malavige et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Yvonne Perrie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
M. J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
MN Oxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents
JR Baldridge et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants
A Hata et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
